watchout

All recalls

Class IIPossible risk

Piastra Mesoram: Mesotherapy injectors

Products labeled as sterile were distributed, but may not have been sterilized.

10 recalled products

  1. PIASTRA MESORAM, MULTI INJECTORS WITHOUT NEEDLES, REF 710104

    Codes on the package: REF 710104, LOTS: 190173017, 190173018, 200173006, 200173009

  2. PIASTRA MESORAM, LINEAR MILTI-INJECTOR WITH NEEDLES FOR MESOTHERAPY, 27G X 4mm, REF 710201

    Codes on the package: REF 710201, LOTS: 200516901

  3. PIASTRA MESORAM, MULTI INJECTORS WITH NEEDLES, 27G X 6mm, REF 710202

    Codes on the package: REF 710202, LOTS: 190517103

  4. PIASTRA MESORAM, CIRCULAR MULTI INJECTORS WITH NEEDLES, 27G X 6mm, REF 710204

    Codes on the package: REF 710204, LOTS: 200506002

  5. PIASTRA MESORAM, MULTI INJECTORS WITH NEEDLES, 27G X 4mm, REF 710205

    Codes on the package: REF 710205, LOTS: 200517802, 190517803, 200517801, 200517803

  6. PIASTRA MESORAM, MULTI INJECTORS WITH NEEDLES, 27G X 6mm, REF 710206

    Codes on the package: REF 710206, LOTS: 190518002, 190518003, 200518001

  7. PIASTRA MESORAM, MULTI INJECTORS WITH NEEDLES, 30G X 6mm, REF 710209

    Codes on the package: REF 710209, LOTS: 200517701, 190517704

  8. PIASTRA MESORAM, MULTI INJECTORS WITH NEEDLES, 30G X 4mm, REF 710214

    Codes on the package: REF 710214, LOTS: 190517601, 190517602

  9. PIASTRA MESORAM, MULTI INJECTORS WITH NEEDLES, 30G X 4mm, REF 710215

    Codes on the package: REF 710215, LOTS: 200516701

  10. MESORAM, HYPODERMIC NEEDLES, MESOTHERAPY, SIZE 30G 0.30 X 4mm, REF 710303

    Codes on the package: REF 710303, LOTS: 190907

If you have this product, don’t eat it or feed it. Throw it away, or return it where you bought it.

Status
In progress (Ongoing)
Type
Pet food
Recalled by
Promaderm Ltd.
Posted by the FDA
Started by the firm
Classified
Sold in
Nationwide

From the FDA

This recall is in the FDA’s Enforcement Report under recall numbers V-0035-2022, V-0036-2022, V-0037-2022, V-0038-2022, V-0039-2022, V-0040-2022, V-0041-2022, V-0042-2022, V-0043-2022, V-0044-2022. The headline above is a summary; the product descriptions are the FDA’s own words.